Irexime

Clindamycin and Benzoyl Peroxide, the active ingredients in Irexime, are an antibiotic (lincosamide) and a keratolytic presented as a topical formulation for skin application. It is indicated for the treatment of acne vulgaris in adolescents and adults. GNH USA supplies Irexime as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Irexime, a combination of clindamycin and benzoyl peroxide, is used in the management of acne vulgaris and related lesions.

Acne vulgaris: reduces inflammatory papules and pustules. Inflammatory acne: decreases redness and swelling of lesions. Non‑inflammatory acne: helps clear comedones and blackheads. Preventive acne care: limits formation of new lesions during treatment.

Topical application of Irexime may cause local skin reactions, most of which are mild and self‑limiting.

Common Side Effects: - Dryness: skin feels tight or flaky. - Irritation: mild burning or stinging at the application site. - Redness: transient erythema. - Peeling: superficial desquamation. - Itching: occasional pruritus. - Contact dermatitis: localized allergic response.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, hives, or difficulty breathing. - Stevens‑Johnson syndrome: widespread skin blistering. - Angioedema: rapid swelling of face or lips. - Photosensitivity: heightened sunburn risk. - Secondary infection: worsening of skin lesions. - Persistent ulceration: non‑healing sores.

Before using Irexime, consider the following safety measures.

Pregnancy: consult a healthcare professional before use. Breastfeeding: discuss potential risks with a physician. Skin integrity: avoid applying on broken, inflamed, or compromised skin. Concurrent topical retinoids: may increase irritation; use sequentially or under guidance. Sun exposure: apply sunscreen and limit UV exposure while using the product. Store at room temperature: keep in the original container, protect from moisture and light.

Irexime can interact with other dermatological agents; awareness of these interactions helps minimise adverse outcomes.

Major Interactions (Avoid): - Oral isotretinoin: may exacerbate skin dryness and irritation. - Topical corticosteroids: can reduce antibacterial efficacy. - Other topical antibiotics: increase risk of bacterial resistance.

Moderate Interactions (Monitor Closely): - Retinoid creams or gels: may heighten local irritation. - Alcohol‑based cleansers: can enhance skin dryness. - Antifungal topicals: potential for overlapping irritation.